Divis Laboratories Ltd reported INR36.76B in Sales Revenues for its fiscal quarter ending in September of 2026.





Sales Change Date
Alaunos Therapeutics USD 2K 2K Mar/2025
Aurobindo Pharma INR 102.63B 11.13B Sep/2026
Avita Medical AUD 21.7M 4.09M Jun/2026
Dianthus Therapeutics USD 761K 298K Jun/2026
Divis Laboratories Ltd INR 36.76B 9.18B Sep/2026
Ionis Pharmaceuticals USD 243M 25M Sep/2026
IQVIA Holdings USD 4.43B 60M Sep/2026
Lupin INR 78.27B 4.5B Sep/2026
Moderna USD 1.31M 98.69M Sep/2026
Organon & Co USD 1.57B 10M Sep/2026
Revvity USD 729M 680K Sep/2026
Tectonic Therapeutic USD 0 0 Dec/2024
Tilray USD 217.51M 74.75M Dec/2025
Viatris USD 3.75B 10M Sep/2026
Xeris Pharmaceuticals USD 92.1M 8.97M Jun/2026